Recursion Pharmaceuticals, Inc. (RXRX)
3.245
-0.26
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
+0.02
(+0.46%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap : 1.733B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.869B |
| August 20, 2026 | 1.784B |
| August 19, 2026 | 1.869B |
| August 18, 2026 | 1.650B |
| August 17, 2026 | 1.661B |
| August 14, 2026 | 1.688B |
| August 13, 2026 | 1.768B |
| August 12, 2026 | 1.757B |
| August 11, 2026 | 1.789B |
| August 10, 2026 | 1.757B |
| August 07, 2026 | 1.720B |
| August 06, 2026 | 1.699B |
| August 05, 2026 | 1.693B |
| August 04, 2026 | 1.768B |
| August 03, 2026 | 1.699B |
| July 31, 2026 | 1.592B |
| July 30, 2026 | 1.613B |
| July 29, 2026 | 1.576B |
| July 28, 2026 | 1.618B |
| July 27, 2026 | 1.597B |
| July 24, 2026 | 1.571B |
| July 23, 2026 | 1.597B |
| July 22, 2026 | 1.581B |
| July 21, 2026 | 1.634B |
| July 20, 2026 | 1.534B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.563B |
| July 16, 2026 | 1.602B |
| July 15, 2026 | 1.756B |
| July 14, 2026 | 1.772B |
| July 13, 2026 | 1.751B |
| July 10, 2026 | 1.889B |
| July 09, 2026 | 1.995B |
| July 08, 2026 | 1.974B |
| July 07, 2026 | 2.038B |
| July 06, 2026 | 2.101B |
| July 02, 2026 | 2.016B |
| July 01, 2026 | 1.947B |
| June 30, 2026 | 1.947B |
| June 29, 2026 | 1.958B |
| June 26, 2026 | 1.868B |
| June 25, 2026 | 1.772B |
| June 24, 2026 | 1.714B |
| June 23, 2026 | 1.677B |
| June 22, 2026 | 1.687B |
| June 18, 2026 | 1.714B |
| June 17, 2026 | 1.650B |
| June 16, 2026 | 1.687B |
| June 15, 2026 | 1.746B |
| June 12, 2026 | 1.671B |
| June 11, 2026 | 1.671B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 8.821B |
| Absci Corp. | 1.519B |
| Novavax, Inc. | 1.459B |
| Editas Medicine, Inc. | 460.59M |
| Dyne Therapeutics, Inc. | 4.307B |
Market Cap Related Metrics
| PS Ratio | 30.10 |
| Price to Book Value | 1.894 |
| Price | 3.245 |
| Earnings Yield | -31.94% |